Xie Chang C - OmicsDI

Show results for

Unknown (529)
Proteomics (30)
Transcriptomics (11)
Metabolomics (6)
Models (1)
Genomics (1)

Organisms

Homo sapiens (26)
Andropogon gerardi (10)
Bacteria (10)
Borrelia (10)
Botrytis cinerea (10)
Canis lupus familiaris (10)
Clostridium perfringens (10)
Cnidaria (10)
Cricetulus griseus (10)
Eukaryota (10)
Fasciola (10)
Hepatitis B virus (10)
Human betaherpesvirus 5 (10)
Japanese encephalitis virus group (10)
Mesocricetus auratus (10)
Miscanthus x giganteus (10)
Mycobacterium tuberculosis (10)
Orthoflavivirus (10)
Panicum virgatum (10)
Platyhelminthes (10)
Pseudomonas aeruginosa AES-1R (10)
Rickettsia (10)
Saccharomyces cerevisiae (10)
Arabidopsis thaliana (1)
Deinococcus radiodurans R1 = ATCC 13939 = DSM 20539 (1)
Escherichia coli (1)
Gossypium hirsutum (1)
Mus (1)
Mus musculus (1)
Saccharomyces cerevisiae (1)

Repository

iProX (19)
biostudies-arrayexpress (11)
pride (10)
MetaboLights (6)
BioModels (1)
EGA (1)
MassIVE (1)

Tissue

Cell culture (3)
Blood plasma (2)
Bone marrow (2)
Blood cell (1)
Blood serum (1)
Brain (1)
Cell suspension culture (1)
Cerebrospinal fluid (1)
Colon (1)
Cotyledon (1)
Dendritic cell (1)
Embryo (1)
Endosperm (1)
Erythrocyte (1)
Heart (1)
Kidney (1)
Leukocyte (1)
Liver (1)
Lung (1)
Lymph node (1)
Placenta (1)
Primary cell (1)
Rosette (1)
Saliva (1)
Spleen (1)
Testis (1)
Urine (1)
Whole body (1)

Disease

Rheumatoid arthritis (1)
Severe acute respiratory syndrome (1)

Technology Type

Mass Spectrometry (10)
Mass spectrometry (6)
Shotgun proteomics (5)
Affinity purification coupled with mass spectrometry proteomics (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
Proteogenomics (1)
SRM/MRM (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (3)
Liquid Chromatography MS - negative - reverse phase (3)
Illumina HiSeq 2500 (1)
NextSeq 500 (1)
Q Exactive Plus (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2023 (7)
2022 (6)
2019 (5)
2012 (5)
2025 (3)
2020 (3)
2011 (2)
2010 (2)
2024 (2)
2021 (2)
2026 (2)
2005 (1)
2017 (1)
2018 (1)

CHEBI ID

CHEBI:90487 (2)
CHEBI:34080 (2)
CHEBI:80705 (2)
CHEBI:84538 (2)
CHEBI:18160 (2)
CHEBI:34671 (2)
CHEBI:90029 (2)
CHEBI:4573 (2)
CHEBI:79113 (2)
CHEBI:75304 (2)
CHEBI:79098 (2)
CHEBI:79096 (2)
CHEBI:84513 (2)
CHEBI:60568 (2)
CHEBI:156029 (2)
CHEBI:136160 (2)
CHEBI:132582 (2)
CHEBI:85850 (2)
CHEBI:1904 (2)
CHEBI:149633 (2)
CHEBI:17211 (2)
CHEBI:74879 (2)
CHEBI:30830 (2)
CHEBI:17973 (2)
CHEBI:42567 (2)
CHEBI:78261 (2)
CHEBI:75565 (2)
CHEBI:62837 (2)
CHEBI:84519 (2)
CHEBI:27605 (2)

Metabolite Name

Deoxycorticosterone acetate (2)
4-imidazoleacetic acid (2)
DL-tryptophan (2)
Dihydromethysticin (2)
Zerumbone (2)
Leucine (2)
Isoliquiritigenin (2)
1-methyladenosine (2)
Betaine (2)
D-ornithine (2)
Genistein (2)
Glycocholate (2)
Benzyl alcohol (2)
Phosphocholine (2)
Pantothenic acid (2)
Acetylcholine (2)
Palmitoyl sphingomyelin (2)
Adenosine (2)
Indole-3-acetamide (2)
Guanine (2)
Cytosine (2)
Pyridoxal (2)
Creatinine (2)
Creatine (2)
Hypoxanthine (2)
PC(41:2p) (1)
SM(d45:1)(rep) (1)
SM(d46:4) (1)
PE(18:0p/22:1) (1)
SM(d43:1) (1)

IsPrivate

False (1)

Model Flag

Non Kinetic (1)

Study type

Transcription profiling by array (10)
RNA-seq of coding RNA (1)

Release Date

2025 (85)
2024 (71)
2022 (65)
2023 (63)
2021 (58)
2020 (42)
2019 (29)
2015 (21)
2017 (20)
2018 (19)
2026 (12)
2016 (12)
2014 (12)
2012 (7)
2011 (7)
2013 (7)
2010 (4)
2009 (4)
2007 (1)
1997 (1)

Lab affiliation

Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA (1)
Department of Orthopedics, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China. (1)
Department of Rheumatology and immunology, Second Xiangya Hospital of South Central University, No.139 Ren Min Department of Rheumatology and immunology, Second Xiangya Hospital of South Central University, No.139 Ren Min Middle Road, Chang Sha,China41001111111rtment of Rheumatology and immunology, Second Xiangya Hospital of South Central University, No.139 Ren Min Mid6969Chang Sha,China410011d, Chang Sha,China410011 (1)
Doctor at Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China (1)
Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm, College of Forestry and Landscape Architecture, South China Agricultural University, Guangzhou 510642, China (1)
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA (1)
School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China (1)
State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China. (1)
State Key Laboratory of Proteomics, National Center for Protein Sciences Beijing, Beijing Proteome Research Center (1)
Translational Biomedical Proteomics, Institute of Molecular and Cell Biology (IMCB), Singapore (1)

Previous page
1 / 58
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 58
Next page

Sort by:

Relevance

Page size

Chang2010_Reduced_Kidney_FBA

This is the reduced kidney metabolic network described in the article Drug off-target effects predicted using structural analysis in the context of a metabolic network model. Chang RL, Xie L, Xie L, Bourne PE, Palsson BØ. PLoS Comput Biol. 2010 Sep 23;...

2005-01-01 | MODEL1011080004 | BioModels

The subfamily Xerocomoideae (Boletaceae, Boletales) in China.

Not available

S-EPMC10825750 | biostudies-literature

Automated bone mineral density prediction and fracture risk assessment using plain radiographs via deep learning.

Not available

S-EPMC8446034 | biostudies-literature

Iron catalyzed C-C dehydrogenative coupling reaction: synthesis of arylquinones from quinones/hydroquinones.

Not available

S-EPMC8979275 | biostudies-literature

MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells.

Deficient DNA repair capacity is associated with genetic lesions accumulation and susceptibility to carcinogenesis. MicroRNAs (miRNAs) are small non-coding RNAs that regulate various cellular pathways including DNA repair. Here we hypothesized that the existence of HBV products may interfere with ce...

ORGANISM(S): Homo sapiens

2011-08-02 | E-GEOD-27561 | biostudies-arrayexpress

Connexin43 mediates NF-κB signalling activation induced by high glucose in GMCs: involvement of c-Src.

Not available

S-EPMC3699363 | biostudies-literature

Evodiamine suppresses non-small cell lung cancer by elevating CD8⁺ T cells and downregulating the MUC1-C/PD-L1 axis.

Not available

S-EPMC7677782 | biostudies-literature

Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.

Not available

S-EPMC4811464 | biostudies-literature

Axially Coordinated Gold Nanoclusters Tailoring Fe-N-C Nanozymes for Enhanced Oxidase-Like Specificity and Activity.